Evidence map›Paper›PMID 33080976›Full record

ArticleInternational journal of molecular sciences2020

The Human Digestive Tract Is Capable of Degrading Gluten from Birth.

Silvia Fernández-Pérez, Jenifer Pérez-Andrés, Sergio Gutiérrez, Nicolás Navasa, Honorina Martínez-Blanco, Miguel Ángel Ferrero, Santiago Vivas, Luis Vaquero, Cristina Iglesias, Javier Casqueiro and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Silvia Fernández-PérezÁrea de Bioquímica y Biología Molecular, Departamento de Biología Molecular, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.
Jenifer Pérez-AndrésÁrea de Microbiología, Departamento de Biología Molecular, Facultad de Ciencias Biológicas y Ambientales, Universidad de León, 24071 León, Spain.
Sergio GutiérrezÁrea de Bioquímica y Biología Molecular, Departamento de Biología Molecular, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.
Nicolás NavasaÁrea de Bioquímica y Biología Molecular, Departamento de Biología Molecular, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.
Honorina Martínez-BlancoÁrea de Bioquímica y Biología Molecular, Departamento de Biología Molecular, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.ORCID 0000-0003-4591-2321
Miguel Ángel FerreroÁrea de Bioquímica y Biología Molecular, Departamento de Biología Molecular, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.
Santiago VivasServicio de Gastroenterología, Hospital Universitario de León, 24008 Léon, Spain.
Luis VaqueroServicio de Gastroenterología, Hospital Universitario de León, 24008 Léon, Spain.
Cristina IglesiasServicio de Gastroenterología, Hospital Universitario de León, 24008 Léon, Spain.
Javier CasqueiroÁrea de Microbiología, Departamento de Biología Molecular, Facultad de Ciencias Biológicas y Ambientales, Universidad de León, 24071 León, Spain.ORCID 0000-0001-9046-2708
Leandro B Rodríguez-AparicioÁrea de Bioquímica y Biología Molecular, Departamento de Biología Molecular, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.ORCID 0000-0002-0372-2055
Universidad de León · ESHospital de León · ES

Funding

Consejería de Educación, Junta de Castilla y León LE032P17Consejería de Educación, Junta de Castilla y León LE283U14Ministerio de Ciencia, Tecnología y Medio Ambiente SAF2015-64306-R
6 · The paper itself

Abstract

The human gastrointestinal system has the capacity to metabolize dietary gluten. The capacity to degrade gliadin-derived peptide is present in humans from birth and increases during the first stages of life (up to 6-12 months of age). Fecal samples from 151 new-born and adult non-celiac disease (NCD) volunteers were collected, and glutenase and glianidase activities were evaluated. The capacity of total fecal proteins to metabolize 33-mer, 19-mer, and 13-mer gliadin peptides was also evaluated by high-performance liquid chromatography (HPLC). Feces from new-borns (meconium) showed glutenase and gliadinase activities, and peptidase activity against all three gliadin peptides. Maximal gluten degradative activity was observed in fecal samples from the youngest volunteers (0-12 months old). After the age of nine months, the gluten digestive capacity of gastrointestinal tract decreases and, from ±8 years old, individuals lose the ability to completely degrade toxic peptides. The gastrointestinal proteases involved in gluten digestion: elastase 2A, elastase 3B, and carboxipeptidase A1 are present from earlier stages of life. The human digestive tract contains the proteins capable of metabolizing gluten from birth, even before starting gluten intake. Humans are born with the ability to digest gluten and to completely degrade the potentially toxic gliadin-derived peptides (33-, 19-, and 13-mer).

Indexed as

ProteolysisAdolescentAdultAge FactorsChildChild, PreschoolDigestionGastrointestinal TractGliadinGlutensHumansHydrolysisInfantInfant, NewbornMiddle AgedPeptide HydrolasesGliadinGlutensPeptide Hydrolasesceliac diseasegastrointestinal tractgliadinase activitygliadin peptidesglutenmeconium

Identifiers

PMID33080976
PMCPMC7589136
OpenAlexW3093449076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.